SA Clinical Nutrition 2 Flashcards
- Crystals vs uroliths.
- Define crystalluria.
- Urolith = urinary stone = macroscopic.
- organised crystal aggregates of minerals in small amounts of organic matrix.
Crystal = microscopic mineral precipitate.
Crystalluria and uroliths may happen separately or together.
- NOT necessarily the same constituents. - Crystals in the urine.
Urolith formation process.
Urine subsaturated - no crystals.
Solubility product (Ksp) - urine saturated with a compound.
Urine supersaturated.
- inhibitors of crystal formation in urine enables holding compound in solution.
Formation product (Kf) - crystals form as compound precipitates out.
Urolith formation can occur.
- Promotors of crystal formation.
- Types of urolith formation.
- Compound concentration increase in the urine.
Increased USG.
Urine pH.
Urine stasis - low frequency of voiding. - Homogenous (pure).
Heterogenous.
- crystal starts to form a stone, or aggregates of crystals form a stone on a central nidus of material e.g. inflammatory material, a different crystal.
- requires less saturation.
General rules for urolith management.
Crystalluria frequently normal, asymptomatic and does not need treatment.
- some crystal types abnormal and require investigation / management.
Uroliths frequently symptomatic need treatment:
- local inflammation.
- secondary infections.
- obstructions.
Uroliths MAY be asymptomatic
- may not need treatment.
– e.g. asymptomatic non-dissolvable uroliths without obstruction risk.
Symptomatic lower urinary uroliths.
Urethroliths lead to obstruction.
- unproductive urination.
Cystoliths lead to cystitis signs.
- +/- bacterial cystitis.
- may also be asymptomatic.
Symptomatic upper urinary uroliths.
Nephroliths:
- abdominal pain, anorexia / inappetence, lethargy.
- +/- pyelonephritis.
- may also be symptomatic.
Ureteroliths:
- cats.
- may present like AKI.
- may present like CKD.
- image every patient with renal/post-renal azotaemia.
- may also be asymptomatic.
Ureteroliths clinical presentation.
Unilateral obstructions may not be azotemic.
- depends on reserve in non-obstructed kidney.
‘Big kidney, little kidney’.
- little = CKD on non-blocked side.
- big = renal swelling / renomegaly on blocked side.
Consider possibility in ANY abdominal pain or inappetent cat.
- much less common in dogs.
Addressing symptomatic uroliths.
Stabilise patient and any hyperkalaemia medically beforehand.
If obstructed, identify site of obstruction.
- Urethra:
– retropulsion of stone into the bladder and remove via cystotomy.
– urethrotomy rarely needed.
–> seek referral if needed.
- Ureter:
– intervention/bypass (referral).
If non-obstructive, in either:
- bladder (cystoliths):
– amenable to dissolution.
–> medical.
– not amenable to dissolution.
–> cystotomy vs minimally invasive techniques e.g. voiding urohydropropulsion / laser therapy w/ cystoscopy.
- kidneys (nephroliths):
– dissolution of nephroliths possible.
– if symptomatic and dissolution not possible –> seek referral advice re. management options.
–> surgical removal.
–> extracorporeal shockwave lithotripsy.
Longer term urolith management.
Patients are stone formers.
- need longer term management.
– some type have predisposing cause, which can be addressed and the patient should not form stones longer term.
Classify stone composition.
- different stones need different management.
Ideally submit for analysis.
- otherwise best guess = signalment, radiopacity, urine pH, underlying disease/predispositions.
Always elucidate pathogenesis where possible.
- underlying disease?
- a concurrent UTI?
- Moderate-markedly radiopaque stones on radiograph.
- Moderately radiolucent stones on radiograph.
- What size do uroliths need to be to visualise on radiograph?
- Uroliths on radiographs.
- Calcium oxalate (more common), struvite (more common), calcium phosphate, silica.
- Urate (more common), cystine, xanthine.
*N.B. stones may become more opaque as they get larger. - > 2-3mm big.
- Plain:
- radiopaque ‘liths.
Contrast/double contrast:
- radiolucent ‘lith.
Ultrasonography.
Operator dependent.
Can visualise radio-opaque and radiolucent ‘liths.
Useful for evaluating renal pelvic dilation due to fluid accumulation.
- used as an indicator of ureteric obstruction.
Urinalysis.
USG - concentrated urine : risk of supersaturation.
pH - may guide likely stone type.
Protein - often increased
– urothelial inflammation.
Blood? Inflammatory cells?
- direct urothelial inflammation from urolith.
- +/- concurrent UTI.
Sediment exam - crystalluria?
– analyse fresh.
– may NOT be concordant with the urolith.
Culture.
How can urine pH help to identify what crystals are present?
Acidic pH = urate (most common), cystine, xanthine, calcium phosphate (brushite).
Acidic to neutral = calcium oxalate (most common), silica.
Alkaline to neutral = calcium phosphate (hydroxyapatite).
Alkaline pH = struvite.
General principles of urolith management.
Dilute urine = supersaturation not possible.
- increase water intake.
– multiple/variable water sources.
– wet diet +/- added water.
- Target USG:
– cats <1.030.
– dogs <1.020.
Encourage voiding.
Avoid obesity.
SPECIFIC management will depend upon stone type.
Uroliths in dogs.
Struvite most common.
- infection associated.
Calcium oxalate.
Urate.
Other types.
Cystoliths (bladder) and urethroliths (urethra) most common sites.